Title

Category IV indications for therapeutic apheresis: ASFA fourth special issue

UMMS Affiliation

Department of Medicine, Division of Transfusion Medicine

Publication Date

2007-03-23

Document Type

Article

Subjects

*Blood Component Removal; Disease; Humans; Practice Guidelines as Topic; Societies, Medical; United States

Disciplines

Hemic and Immune Systems | Other Medical Specialties

Abstract

The American Society for Apheresis (ASFA) Committee on Clinical Applications systematically and critically reviews published information on the use of therapeutic apheresis in clinical practice. On the basis of this review, selected diseases are assigned one of five categories (category I, II, III, IV, and P). The diseases, which were classified as category IV indications, and the rationale for such assignment are reviewed in this article. The diseases assigned to category I, II, III, and newly created category P are discussed in a separate article in this issue.

DOI of Published Version

10.1002/jca.20131

Source

J Clin Apher. 2007 Jun;22(3):176-80. Link to article on publisher's site

Journal/Book/Conference Title

Journal of clinical apheresis

Related Resources

Link to Article in PubMed

PubMed ID

17377982

Share

COinS